Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Early Results of MT-401 (Zedenoleucel) in Post-Transplant MRD + aml Patients

Blood (2022) 140 (Supplement 1): 12718–12719.

https://doi.org/10.1182/blood-2022-155602

Published: 2022

Journal Articles

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Blood (2022) 139 (17): 2706–2711.

https://doi.org/10.1182/blood.2021014648

Published: 2022

Includes: Supplemental data

Journal Articles

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Blood (2021) 137 (19): 2585–2597.

https://doi.org/10.1182/blood.2020009471

Published: 2021

Includes: Supplemental data

Journal Articles

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

George Carrum, MD, Premal Lulla, MBBS, Ifigeneia Tzannou, MD, Ayumi Watanabe, Manik Kuvalekar, Mrinalini Bilgi, Rammurti Kamble, MD, Carlos A. Ramos, MD, Rayne Rouce, MD, Bambi J. Grilley, RPh, Adrian P. Gee, PhD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MDDSc, Cliona M. Rooney, PhD, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2018-99-113140

Published: 2018

Journal Articles

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Swati Naik, MBBS, Premal Lulla, MBBS, Ifigeneia Tzannou, MD, Robert A. Krance, MD, George Carrum, MD, Rammurti Kamble, MD, Carlos A. Ramos, MD, Catherine Robertson, Manik Kuvalekar, Ayumi Watanabe, Bambi J. Grilley, RPh, Juan F. Vera, MD, Helen E. Heslop, MDDSc, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 2693.

https://doi.org/10.1182/blood-2018-99-115465

Published: 2018

Journal Articles

Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma

Premal Lulla, MBBS, Ifigeneia Tzannou, MD, George Carrum, MD, Carlos A. Ramos, MD, Rammurti Kamble, MD, Mrinalini Bilgi, Shivani Mukhi, Betty Chung, DO,MPH,MA, Ayumi Watanabe, Manik Kuvalekar, Adrian P. Gee, PhD, Bambi J. Grilley, RPh, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MDDSc, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 1014.

https://doi.org/10.1182/blood-2018-99-113118

Published: 2018

Journal Articles

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 4484.

https://doi.org/10.1182/blood.V130.Suppl_1.4484.4484

Published: 2017

Journal Articles

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

Premal Lulla, MBBS, Ifigeneia Tzannou, MD, Daniel Brenner, Helen E. Heslop, MDDSc, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2017) 130 (Supplement 1): 1907.

https://doi.org/10.1182/blood.V130.Suppl_1.1907.1907

Published: 2017

Journal Articles

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Premal Lulla, MBBS, Swati Naik, MBBS, Ifigeneia Tzannou, MD, Carlos A. Ramos, MD, Rammurti Kamble, MD, Catherine Robertson, Ayumi Watanabe, Manik Kuvalekar, Bambi J. Grilley, RPh, George Carrum, MD, Helen E. Heslop, MDDSc, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2017) 130 (Supplement 1): 164.

https://doi.org/10.1182/blood.V130.Suppl_1.164.164

Published: 2017

Journal Articles

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Ann Leen, PhD, Ifigeneia Tzannou, MD, Munu Bilgi, Hao Liu, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD, Rammurti T Kamble, MD, Carlos A. Ramos, MD, Bambi Grilley, RPh, Adrian P. Gee, PhD, Catherine M. Bollard, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, George Carrum, MD

Blood (2015) 126 (23): 186.

https://doi.org/10.1182/blood.V126.23.186.186

Published: 2015

Journal Articles

Safety and Clinical Efficacy Of Rapidly-Generated Virus-Specific T Cells With Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered After Allogeneic Hematopoietic Stem Cell Transplant

Anastasia Papadopoulou, Usha L Katari, Ulrike Gerdemann, Caridad Martinez, MD, Kathryn Leung, George Carrum, Adrian P. Gee, PhD, Juan F Vera, Robert A. Krance, MD, Malcolm K. Brenner, Cliona M Rooney, PhD, Helen E. Heslop, MD, Ann Leen, PhD

Blood (2013) 122 (21): 148.

https://doi.org/10.1182/blood.V122.21.148.148

Published: 2013

Journal Articles

Optimizing the Manufacture of CAR-T Cells for Clinical Applications

Pradip Bajgain, Roopa Mucharla, Usanarat Anurathapan, Natalia Lapteva, Ann M. Leen, PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Juan F. Vera, MD

Blood (2012) 120 (21): 348.

https://doi.org/10.1182/blood.V120.21.348.348

Published: 2012

Journal Articles

Genetic Modification of Multi Leukemia Antigen-Specific Cytotoxic T Lymphocytes (CTL) to Enhance In Vivo Safety and Persistency

Fabian Zohren, MD, Maria R Imperato, Anurathapan Usanarat, MD, David M Spencer, PhD, Helen E. Heslop, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Cliona M. Rooney, PhD, Ann M. Leen, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD

Blood (2011) 118 (21): 644.

https://doi.org/10.1182/blood.V118.21.644.644

Published: 2011

Journal Articles

Rapid High Titer Retroviral Production Using a Concentrated Retrovirus Expansion Device (CRED).

Juan F Vera, MD, Gianpietro Dotti, MD, John Wilson, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath

Blood (2009) 114 (22): 2468.

https://doi.org/10.1182/blood.V114.22.2468.2468

Published: 2009

Journal Articles

CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo.

Silke Landmeier, PhD, Bianca Altvater, PhD, Sibylle Pscherer, Jutta Meltzer, Josef Vormoor, MD, FRCPCH, Juan F Vera, MD, Martin Pule, MD, Marc Hotfilder, PhD, Heribert Juergens, MD, Claudia Rossig, MD

Blood (2009) 114 (22): 3025.

https://doi.org/10.1182/blood.V114.22.3025.3025

Published: 2009

Journal Articles

Rapid Generation of Antigen-Specific T Cells for Pre-Clinical and Clinical Applications Using a Novel Mini Cell Bioreactor

Juan F Vera, MD, Lara Brenner, Ann M. Leen, Helen E. Heslop, Gianpietro Dotti, John Wilson, Cliona M. Rooney

Blood (2008) 112 (11): 208.

https://doi.org/10.1182/blood.V112.11.208.208

Published: 2008

Journal Articles

Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients.

Ulrike Gerdemann, MD, Anne Christin, MD, Carlos A. Ramos, MD, Yuriko Fujita, MD, Juan F. Vera, MD, Dagmar Dilloo, MD, Malcolm K. Brenner, MD, PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Ann M. Leen, PhD

Blood (2008) 112 (11): 2207.

https://doi.org/10.1182/blood.V112.11.2207.2207

Published: 2008

Journal Articles

Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy

Valentina Hoyos, MD, Barbara Savoldo, MD, Juan F Vera, MD, Concetta Quintarelli, PhD, Cliona M Rooney, PhD, Helen E. Heslop, MD, Malcolm K Brenner, MD, PhD, Gianpietro Dotti, MD

Blood (2008) 112 (11): 824.

https://doi.org/10.1182/blood.V112.11.824.824

Published: 2008

Journal Articles

Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9

Juan F Vera, MD, Valentina Hoyos, MD, Barbara Savoldo, MD, Concetta Quintarelli, PhD, Greta A Giordano, Ann M. Leen, PhD, Hao Liu, Aaron E. Foster, PhD, Helen E. Heslop, MD, Cliona M Rooney, PhD, Malcolm K Brenner, MD, PhD, Gianpietro Dotti, MD

Blood (2008) 112 (11): 3534.

https://doi.org/10.1182/blood.V112.11.3534.3534

Published: 2008

Journal Articles

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes

Concetta Quintarelli, Juan F. Vera, Barbara Savoldo, Greta M. P. Giordano Attianese, Martin Pule, Aaron E. Foster, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Gianpietro Dotti

Blood (2007) 110 (8): 2793–2802.

https://doi.org/10.1182/blood-2007-02-072843

Published: 2007

Includes: Supplemental data

NARROW

Early Results of MT-401 (Zedenoleucel) in Post-Transplant MRD + aml Patients

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Safety and Clinical Efficacy Of Rapidly-Generated Virus-Specific T Cells With Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered After Allogeneic Hematopoietic Stem Cell Transplant

Optimizing the Manufacture of CAR-T Cells for Clinical Applications

Genetic Modification of Multi Leukemia Antigen-Specific Cytotoxic T Lymphocytes (CTL) to Enhance In Vivo Safety and Persistency

Rapid High Titer Retroviral Production Using a Concentrated Retrovirus Expansion Device (CRED).

CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo.

Rapid Generation of Antigen-Specific T Cells for Pre-Clinical and Clinical Applications Using a Novel Mini Cell Bioreactor

Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients.

Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy

Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only